CGRP May Offer Both Migraine Treatment and Prevention ...Middle East

Medscape - News
Oral rimegepant, the first calcitonin gene-related peptide (CGRP) receptor antagonist approved for the acute treatment of migraine, was superior to placebo in preventing migraine in a phase 2/3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( CGRP May Offer Both Migraine Treatment and Prevention )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News